
BPMC Valuation
Blueprint Medicines Corp
- Overview
- Forecast
- Valuation
- Earnings
BPMC Relative Valuation
BPMC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BPMC is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
24.40
P/B
Median3y
16.18
Median5y
11.41
-1.80
FCF Yield
Median3y
-9.91
Median5y
-6.03
Competitors Valuation Multiple
The average P/S ratio for BPMC's competitors is 8.03, providing a benchmark for relative valuation. Blueprint Medicines Corp Corp (BPMC) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 55.45%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

MOD
Modine Manufacturing Co
103.710
USD
+5.97%

STVN
Stevanato Group SpA
26.510
USD
-5.15%

HALO
Halozyme Therapeutics Inc
58.240
USD
-0.90%

CIGI
Colliers International Group Inc
142.370
USD
+0.45%

VIPS
Vipshop Holdings Ltd
15.980
USD
-0.93%

SPXC
SPX Technologies Inc
180.820
USD
+3.08%

CWAN
Clearwater Analytics Holdings Inc
21.320
USD
+0.90%

WTS
Watts Water Technologies Inc
252.780
USD
+0.32%

CWST
Casella Waste Systems Inc
108.970
USD
+0.17%

LEVI
Levi Strauss & Co
20.450
USD
-0.54%
FAQ

Is Blueprint Medicines Corp (BPMC) currently overvalued or undervalued?
Blueprint Medicines Corp (BPMC) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -24.72. The fair price of Blueprint Medicines Corp (BPMC) is between to according to relative valuation methord.

What is Blueprint Medicines Corp (BPMC) fair value?

How does BPMC's valuation metrics compare to the industry average?

What is the current P/B ratio for Blueprint Medicines Corp (BPMC) as of Jul 27 2025?

What is the current FCF Yield for Blueprint Medicines Corp (BPMC) as of Jul 27 2025?

What is the current Forward P/E ratio for Blueprint Medicines Corp (BPMC) as of Jul 27 2025?
